Global Diabetic Neuropathy Drugs Market to 2023 - Key Vendors are Daiichi Sankyo Co, Eli Lilly and Co, Johnson & Johnson Services, Novartis, & Pfizer

News provided by

May 02, 2019, 12:00 ET

DUBLIN, May 2, 2019 /PRNewswire/ -- The "Global Diabetic Neuropathy Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The diabetic neuropathy drugs market will register a CAGR of about 6% by 2023.

The rising awareness about diabetic neuropathy is one of the prominent factors likely to contribute to the diabetic neuropathy drugs market growth in the forthcoming years. Several awareness programs are being launched among the consumers with an aim to educate and train diabetes educators in the emerging and advanced economies. Different campaigns are encouraging people to take an online test for knowing about the risk factors associated with prediabetes, in turn, driving the diabetic neuropathy drugs market growth during the forecast period.

Market Overview

New drug approvals and strong drug pipeline

One of the growth drivers of the global diabetic neuropathy drugs market is new drug approvals and strong drug pipeline. With the rising prevalence of diabetic neuropathy, several market players are focusing on the development of disease-modifying drugs to treat the disease.

Side-effects of major drugs

One of the challenges in the growth of the global diabetic neuropathy drugs market is the side-effects of major drugs. Side-effects associated with approved drugs such as pregabalin (LYRICA) and gabapentin (NEURONTIN) can lead to low patient compliance, thereby hindering the growth of the market.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on the development of novel biologics to treat diabetic neuropathy. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis

PART 04: MARKET SIZING

Market definition
Market sizing 2018
Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 06: CUSTOMER LANDSCAPE

PART 07: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity

PART 08: MARKET SEGMENTATION BY MECHANISM OF ACTION

Market segmentation by mechanism of action
Comparison by mechanism of action
Calcium channel alpha-2-delta ligand - Market size and forecast 2018-2023
SNRIs and TCAs - Market size and forecast 2018-2023
Others - Market size and forecast 2018-2023
Market opportunity by mechanism of action

PART 09: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

PART 12: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
Daiichi Sankyo Company, Limited
Eli Lilly and Company
Johnson & Johnson Services, Inc.
Novartis AG
Pfizer Inc.

PART 13: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/r/drx6lk

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets